Hunan Jingfeng Pharmaceutical

Hunan Jingfeng Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of high-end chemical drugs and biological products. The company's core portfolio focuses on therapeutic areas such as cardiovascular and cerebrovascular diseases, orthopedics, and oncology. Key products include Sodium Hyaluronate injections for osteoarthritis and various traditional Chinese medicine-derived injections like Shenmai. Jingfeng operates multiple manufacturing bases across China and maintains a presence in both the domestic and international markets. Despite recent financial restructuring efforts, it remains a significant player in the Chinese generic and specialty drug space.